eye allergy itch relief
Generic: olopatadine hcl
0.2 % — Drops
Coverage by Insurer
Informational only — Coverage rules change frequently; verify tier placement and restrictions with your plan or pharmacy before acting.
Blue Cross Blue Shield Federal
3 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
BCBS Federal Standard Option 2026
via olopatadine hcl |
Tier 1 - Generic | — | — | — | None |
|
BCBS Federal Basic Option 2026
via olopatadine hcl |
Tier 1 - Generic | — | — | — | None |
|
BCBS Federal Focus 2026
via olopatadine hcl |
Tier 1 - Generic | — | — | — | None |
TRICARE
2 plans| Plan | Tier | Prior Auth | Step Therapy | Quantity Limit | Restrictions |
|---|---|---|---|---|---|
|
TRICARE Uniform Formulary 2026
via olopatadine hcl |
Tier 1 - Generic Formulary (Basic Core) | ✓ | ✓ | ✓ PATANASE (PS 30.5) LTD TO A MAX QTY OF 1 INHALER PER DISPENSING AT RETAIL OR 3 INHALERS AT MAIL | PA | ST | QL PA on 18 of 44 NDCs: 1270/48001/90693 PA DRUGS, DOD PA REQUIRED; Step therapy on 6 of 44 NDCs: SEL ANTIHISTAMINE/STEROIDS NS PT >4 W/O OR W/O ASTELIN,ATROVENT,FLONASE,FLUNISOLIDE NS IN 180D REQPA; Quantity limit on 6 of 44 NDCs |
| TRICARE Uniform Formulary 2026 | Tier 4 - Not Covered | ✓ | — | — | PA PA: 1270/48001/90693 PA DRUGS, DOD PA REQUIRED |